Cita APA

Kwarteng, A., Asiedu, E., Sylverken, A., Larbi, A., Mubarik, Y., & Apprey, C. (2021). In silico drug repurposing for filarial infection predicts nilotinib and paritaprevir as potential inhibitors of the Wolbachia 5′-aminolevulinic acid synthase. Sci Rep.

Chicago Style Citation

Kwarteng, Alexander, Ebenezer Asiedu, Augustina Sylverken, Amma Larbi, Yusif Mubarik, i Charles Apprey. "In Silico Drug Repurposing for Filarial Infection Predicts Nilotinib and Paritaprevir As Potential Inhibitors of the Wolbachia 5′-aminolevulinic Acid Synthase." Sci Rep 2021.

Cita MLA

Kwarteng, Alexander, et al. "In Silico Drug Repurposing for Filarial Infection Predicts Nilotinib and Paritaprevir As Potential Inhibitors of the Wolbachia 5′-aminolevulinic Acid Synthase." Sci Rep 2021.